nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RXRB—stomach cancer	0.358	0.591	CbGaD
Alitretinoin—RARB—stomach cancer	0.248	0.409	CbGaD
Alitretinoin—ABCB1—Mitomycin—stomach cancer	0.0351	0.5	CbGbCtD
Alitretinoin—CYP1A2—Fluorouracil—stomach cancer	0.00987	0.141	CbGbCtD
Alitretinoin—ABCB1—Irinotecan—stomach cancer	0.009	0.128	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—stomach cancer	0.00659	0.0939	CbGbCtD
Alitretinoin—ABCB1—Doxorubicin—stomach cancer	0.00491	0.07	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—stomach cancer	0.00476	0.0678	CbGbCtD
Alitretinoin—CRABP1—hematopoietic system—stomach cancer	0.00213	0.0731	CbGeAlD
Alitretinoin—CRABP2—smooth muscle tissue—stomach cancer	0.0017	0.0582	CbGeAlD
Alitretinoin—CRABP2—pancreas—stomach cancer	0.00157	0.0538	CbGeAlD
Alitretinoin—RARG—hematopoietic system—stomach cancer	0.00141	0.0482	CbGeAlD
Alitretinoin—CRABP2—digestive system—stomach cancer	0.00134	0.046	CbGeAlD
Alitretinoin—RARA—hematopoietic system—stomach cancer	0.00132	0.0454	CbGeAlD
Alitretinoin—RXRB—pancreas—stomach cancer	0.00129	0.0443	CbGeAlD
Alitretinoin—CRABP1—endocrine gland—stomach cancer	0.00123	0.042	CbGeAlD
Alitretinoin—Acitretin—RBP1—stomach cancer	0.00121	0.158	CrCbGaD
Alitretinoin—Vitamin A—ALDH1A3—stomach cancer	0.00112	0.146	CrCbGaD
Alitretinoin—CRABP2—endocrine gland—stomach cancer	0.00111	0.038	CbGeAlD
Alitretinoin—RXRA—endocrine gland—stomach cancer	0.0011	0.0378	CbGeAlD
Alitretinoin—Tretinoin—RARRES1—stomach cancer	0.00108	0.141	CrCbGaD
Alitretinoin—RXRA—liver—stomach cancer	0.000995	0.0341	CbGeAlD
Alitretinoin—RARB—endocrine gland—stomach cancer	0.000992	0.034	CbGeAlD
Alitretinoin—RARG—digestive system—stomach cancer	0.000979	0.0335	CbGeAlD
Alitretinoin—RXRG—endocrine gland—stomach cancer	0.000969	0.0332	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—stomach cancer	0.000932	0.0319	CbGeAlD
Alitretinoin—RXRB—endocrine gland—stomach cancer	0.000911	0.0312	CbGeAlD
Alitretinoin—RARB—liver—stomach cancer	0.000894	0.0306	CbGeAlD
Alitretinoin—RARA—bone marrow—stomach cancer	0.000848	0.0291	CbGeAlD
Alitretinoin—Vitamin A—RBP1—stomach cancer	0.000846	0.111	CrCbGaD
Alitretinoin—RXRB—liver—stomach cancer	0.000822	0.0282	CbGeAlD
Alitretinoin—RARA—endocrine gland—stomach cancer	0.00076	0.0261	CbGeAlD
Alitretinoin—RARA—liver—stomach cancer	0.000686	0.0235	CbGeAlD
Alitretinoin—RARB—lymph node—stomach cancer	0.000685	0.0235	CbGeAlD
Alitretinoin—Isotretinoin—RXRB—stomach cancer	0.000653	0.0855	CrCbGaD
Alitretinoin—RARG—lymph node—stomach cancer	0.000559	0.0192	CbGeAlD
Alitretinoin—Acitretin—RXRB—stomach cancer	0.000555	0.0727	CrCbGaD
Alitretinoin—Vitamin A—RBP4—stomach cancer	0.000545	0.0713	CrCbGaD
Alitretinoin—RARA—lymph node—stomach cancer	0.000526	0.018	CbGeAlD
Alitretinoin—CYP1A2—hematopoietic system—stomach cancer	0.000491	0.0168	CbGeAlD
Alitretinoin—ABCB1—blood vessel—stomach cancer	0.000472	0.0162	CbGeAlD
Alitretinoin—Isotretinoin—RARB—stomach cancer	0.000453	0.0593	CrCbGaD
Alitretinoin—Acitretin—RARB—stomach cancer	0.000385	0.0504	CrCbGaD
Alitretinoin—Tretinoin—RXRB—stomach cancer	0.000375	0.0491	CrCbGaD
Alitretinoin—CYP1A2—digestive system—stomach cancer	0.000341	0.0117	CbGeAlD
Alitretinoin—CYP1A2—endocrine gland—stomach cancer	0.000282	0.00966	CbGeAlD
Alitretinoin—Tretinoin—RARB—stomach cancer	0.00026	0.034	CrCbGaD
Alitretinoin—CYP1A2—liver—stomach cancer	0.000254	0.00871	CbGeAlD
Alitretinoin—ABCB1—hematopoietic system—stomach cancer	0.000251	0.00862	CbGeAlD
Alitretinoin—ABCB1—epithelium—stomach cancer	0.00023	0.00788	CbGeAlD
Alitretinoin—ABCB1—pancreas—stomach cancer	0.000205	0.00702	CbGeAlD
Alitretinoin—ABCB1—lymphoid tissue—stomach cancer	0.000177	0.00607	CbGeAlD
Alitretinoin—ABCB1—digestive system—stomach cancer	0.000175	0.00599	CbGeAlD
Alitretinoin—ABCB1—bone marrow—stomach cancer	0.000161	0.00552	CbGeAlD
Alitretinoin—ABCB1—endocrine gland—stomach cancer	0.000144	0.00495	CbGeAlD
Alitretinoin—ABCB1—liver—stomach cancer	0.00013	0.00446	CbGeAlD
Alitretinoin—Tretinoin—CYP2A6—stomach cancer	0.000104	0.0136	CrCbGaD
Alitretinoin—ABCB1—lymph node—stomach cancer	9.99e-05	0.00342	CbGeAlD
Alitretinoin—Acitretin—ALB—stomach cancer	6.01e-05	0.00787	CrCbGaD
Alitretinoin—Mental disorder—Methotrexate—stomach cancer	4.29e-05	0.00029	CcSEcCtD
Alitretinoin—Eye disorder—Epirubicin—stomach cancer	4.28e-05	0.00029	CcSEcCtD
Alitretinoin—Tinnitus—Epirubicin—stomach cancer	4.27e-05	0.000289	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—stomach cancer	4.26e-05	0.000288	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—stomach cancer	4.26e-05	0.000288	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—stomach cancer	4.26e-05	0.000288	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Capecitabine—stomach cancer	4.25e-05	0.000288	CcSEcCtD
Alitretinoin—Flushing—Epirubicin—stomach cancer	4.25e-05	0.000288	CcSEcCtD
Alitretinoin—Vomiting—Fluorouracil—stomach cancer	4.25e-05	0.000288	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—stomach cancer	4.25e-05	0.000287	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—stomach cancer	4.24e-05	0.000287	CcSEcCtD
Alitretinoin—Hepatitis—Doxorubicin—stomach cancer	4.24e-05	0.000287	CcSEcCtD
Alitretinoin—Insomnia—Capecitabine—stomach cancer	4.22e-05	0.000286	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—stomach cancer	4.22e-05	0.000285	CcSEcCtD
Alitretinoin—Rash—Fluorouracil—stomach cancer	4.21e-05	0.000285	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—stomach cancer	4.21e-05	0.000285	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—stomach cancer	4.2e-05	0.000285	CcSEcCtD
Alitretinoin—Paraesthesia—Capecitabine—stomach cancer	4.19e-05	0.000284	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—stomach cancer	4.19e-05	0.000284	CcSEcCtD
Alitretinoin—Headache—Fluorouracil—stomach cancer	4.19e-05	0.000283	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—stomach cancer	4.18e-05	0.000283	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—stomach cancer	4.17e-05	0.000282	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—stomach cancer	4.16e-05	0.000282	CcSEcCtD
Alitretinoin—Dyspnoea—Capecitabine—stomach cancer	4.16e-05	0.000282	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—stomach cancer	4.16e-05	0.000281	CcSEcCtD
Alitretinoin—Angiopathy—Epirubicin—stomach cancer	4.15e-05	0.000281	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—stomach cancer	4.15e-05	0.000281	CcSEcCtD
Alitretinoin—Nausea—Irinotecan—stomach cancer	4.14e-05	0.00028	CcSEcCtD
Alitretinoin—Pain—Docetaxel—stomach cancer	4.12e-05	0.000279	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—stomach cancer	4.12e-05	0.000279	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—stomach cancer	4.12e-05	0.000279	CcSEcCtD
Alitretinoin—Dyspepsia—Capecitabine—stomach cancer	4.11e-05	0.000278	CcSEcCtD
Alitretinoin—Chills—Epirubicin—stomach cancer	4.11e-05	0.000278	CcSEcCtD
Alitretinoin—Arrhythmia—Epirubicin—stomach cancer	4.09e-05	0.000277	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—stomach cancer	4.08e-05	0.000276	CcSEcCtD
Alitretinoin—Decreased appetite—Capecitabine—stomach cancer	4.06e-05	0.000275	CcSEcCtD
Alitretinoin—Alopecia—Epirubicin—stomach cancer	4.05e-05	0.000274	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Capecitabine—stomach cancer	4.03e-05	0.000273	CcSEcCtD
Alitretinoin—Fatigue—Capecitabine—stomach cancer	4.03e-05	0.000272	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—stomach cancer	4.01e-05	0.000272	CcSEcCtD
Alitretinoin—Mental disorder—Epirubicin—stomach cancer	4.01e-05	0.000271	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—stomach cancer	4.01e-05	0.000271	CcSEcCtD
Alitretinoin—Constipation—Capecitabine—stomach cancer	3.99e-05	0.00027	CcSEcCtD
Alitretinoin—Pain—Capecitabine—stomach cancer	3.99e-05	0.00027	CcSEcCtD
Alitretinoin—Erythema—Epirubicin—stomach cancer	3.99e-05	0.00027	CcSEcCtD
Alitretinoin—Malnutrition—Epirubicin—stomach cancer	3.99e-05	0.00027	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—stomach cancer	3.97e-05	0.000269	CcSEcCtD
Alitretinoin—Nausea—Fluorouracil—stomach cancer	3.97e-05	0.000269	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—stomach cancer	3.96e-05	0.000268	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—stomach cancer	3.95e-05	0.000267	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—stomach cancer	3.95e-05	0.000267	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—stomach cancer	3.94e-05	0.000267	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—stomach cancer	3.94e-05	0.000266	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—stomach cancer	3.93e-05	0.000266	CcSEcCtD
Alitretinoin—Flatulence—Epirubicin—stomach cancer	3.93e-05	0.000266	CcSEcCtD
Alitretinoin—Tension—Epirubicin—stomach cancer	3.91e-05	0.000265	CcSEcCtD
Alitretinoin—Nervousness—Epirubicin—stomach cancer	3.87e-05	0.000262	CcSEcCtD
Alitretinoin—Back pain—Epirubicin—stomach cancer	3.86e-05	0.000261	CcSEcCtD
Alitretinoin—Feeling abnormal—Capecitabine—stomach cancer	3.85e-05	0.00026	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—stomach cancer	3.84e-05	0.00026	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—stomach cancer	3.84e-05	0.00026	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Capecitabine—stomach cancer	3.82e-05	0.000258	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—stomach cancer	3.81e-05	0.000258	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—stomach cancer	3.81e-05	0.000258	CcSEcCtD
Alitretinoin—Chills—Doxorubicin—stomach cancer	3.8e-05	0.000257	CcSEcCtD
Alitretinoin—Arrhythmia—Doxorubicin—stomach cancer	3.78e-05	0.000256	CcSEcCtD
Alitretinoin—Vision blurred—Epirubicin—stomach cancer	3.76e-05	0.000254	CcSEcCtD
Alitretinoin—Alopecia—Doxorubicin—stomach cancer	3.74e-05	0.000253	CcSEcCtD
Alitretinoin—Cough—Methotrexate—stomach cancer	3.72e-05	0.000252	CcSEcCtD
Alitretinoin—Mental disorder—Doxorubicin—stomach cancer	3.71e-05	0.000251	CcSEcCtD
Alitretinoin—Urticaria—Capecitabine—stomach cancer	3.71e-05	0.000251	CcSEcCtD
Alitretinoin—Ill-defined disorder—Epirubicin—stomach cancer	3.7e-05	0.00025	CcSEcCtD
Alitretinoin—Abdominal pain—Capecitabine—stomach cancer	3.69e-05	0.00025	CcSEcCtD
Alitretinoin—Body temperature increased—Capecitabine—stomach cancer	3.69e-05	0.00025	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—stomach cancer	3.69e-05	0.00025	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—stomach cancer	3.69e-05	0.00025	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—stomach cancer	3.69e-05	0.00025	CcSEcCtD
Alitretinoin—Anaemia—Epirubicin—stomach cancer	3.68e-05	0.000249	CcSEcCtD
Alitretinoin—Agitation—Epirubicin—stomach cancer	3.66e-05	0.000248	CcSEcCtD
Alitretinoin—Flatulence—Doxorubicin—stomach cancer	3.63e-05	0.000246	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—stomach cancer	3.63e-05	0.000245	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—stomach cancer	3.63e-05	0.000245	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—stomach cancer	3.63e-05	0.000245	CcSEcCtD
Alitretinoin—Tension—Doxorubicin—stomach cancer	3.62e-05	0.000245	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	3.6e-05	0.000244	CcSEcCtD
Alitretinoin—Malaise—Epirubicin—stomach cancer	3.59e-05	0.000243	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—stomach cancer	3.58e-05	0.000242	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—stomach cancer	3.58e-05	0.000242	CcSEcCtD
Alitretinoin—Syncope—Epirubicin—stomach cancer	3.57e-05	0.000242	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—stomach cancer	3.57e-05	0.000241	CcSEcCtD
Alitretinoin—Hypersensitivity—Docetaxel—stomach cancer	3.55e-05	0.00024	CcSEcCtD
Alitretinoin—Palpitations—Epirubicin—stomach cancer	3.52e-05	0.000238	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—stomach cancer	3.51e-05	0.000237	CcSEcCtD
Alitretinoin—Loss of consciousness—Epirubicin—stomach cancer	3.5e-05	0.000237	CcSEcCtD
Alitretinoin—Cough—Epirubicin—stomach cancer	3.48e-05	0.000235	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—stomach cancer	3.48e-05	0.000235	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—stomach cancer	3.48e-05	0.000235	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—stomach cancer	3.46e-05	0.000234	CcSEcCtD
Alitretinoin—Convulsion—Epirubicin—stomach cancer	3.45e-05	0.000234	CcSEcCtD
Alitretinoin—Infection—Methotrexate—stomach cancer	3.45e-05	0.000234	CcSEcCtD
Alitretinoin—Hypertension—Epirubicin—stomach cancer	3.44e-05	0.000233	CcSEcCtD
Alitretinoin—Hypersensitivity—Capecitabine—stomach cancer	3.44e-05	0.000233	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—stomach cancer	3.42e-05	0.000232	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—stomach cancer	3.41e-05	0.000231	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—stomach cancer	3.41e-05	0.000231	CcSEcCtD
Alitretinoin—Anaemia—Doxorubicin—stomach cancer	3.41e-05	0.000231	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—stomach cancer	3.4e-05	0.00023	CcSEcCtD
Alitretinoin—Chest pain—Epirubicin—stomach cancer	3.39e-05	0.00023	CcSEcCtD
Alitretinoin—Myalgia—Epirubicin—stomach cancer	3.39e-05	0.00023	CcSEcCtD
Alitretinoin—Arthralgia—Epirubicin—stomach cancer	3.39e-05	0.00023	CcSEcCtD
Alitretinoin—Agitation—Doxorubicin—stomach cancer	3.39e-05	0.000229	CcSEcCtD
Alitretinoin—Anxiety—Epirubicin—stomach cancer	3.38e-05	0.000229	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—stomach cancer	3.38e-05	0.000228	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	3.37e-05	0.000228	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—stomach cancer	3.36e-05	0.000227	CcSEcCtD
Alitretinoin—Discomfort—Epirubicin—stomach cancer	3.35e-05	0.000227	CcSEcCtD
Alitretinoin—Asthenia—Capecitabine—stomach cancer	3.35e-05	0.000227	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—stomach cancer	3.33e-05	0.000225	CcSEcCtD
Alitretinoin—Dry mouth—Epirubicin—stomach cancer	3.32e-05	0.000225	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—stomach cancer	3.31e-05	0.000224	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—stomach cancer	3.31e-05	0.000224	CcSEcCtD
Alitretinoin—Pruritus—Capecitabine—stomach cancer	3.3e-05	0.000224	CcSEcCtD
Alitretinoin—Diarrhoea—Docetaxel—stomach cancer	3.3e-05	0.000223	CcSEcCtD
Alitretinoin—Confusional state—Epirubicin—stomach cancer	3.28e-05	0.000222	CcSEcCtD
Alitretinoin—Palpitations—Doxorubicin—stomach cancer	3.26e-05	0.000221	CcSEcCtD
Alitretinoin—Anaphylactic shock—Epirubicin—stomach cancer	3.25e-05	0.00022	CcSEcCtD
Alitretinoin—Oedema—Epirubicin—stomach cancer	3.25e-05	0.00022	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—stomach cancer	3.25e-05	0.00022	CcSEcCtD
Alitretinoin—Loss of consciousness—Doxorubicin—stomach cancer	3.24e-05	0.000219	CcSEcCtD
Alitretinoin—Infection—Epirubicin—stomach cancer	3.23e-05	0.000219	CcSEcCtD
Alitretinoin—Cough—Doxorubicin—stomach cancer	3.22e-05	0.000218	CcSEcCtD
Alitretinoin—Shock—Epirubicin—stomach cancer	3.2e-05	0.000217	CcSEcCtD
Alitretinoin—Convulsion—Doxorubicin—stomach cancer	3.2e-05	0.000216	CcSEcCtD
Alitretinoin—Diarrhoea—Capecitabine—stomach cancer	3.19e-05	0.000216	CcSEcCtD
Alitretinoin—Nervous system disorder—Epirubicin—stomach cancer	3.19e-05	0.000216	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—stomach cancer	3.19e-05	0.000216	CcSEcCtD
Alitretinoin—Thrombocytopenia—Epirubicin—stomach cancer	3.19e-05	0.000216	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—stomach cancer	3.18e-05	0.000215	CcSEcCtD
Alitretinoin—Tachycardia—Epirubicin—stomach cancer	3.17e-05	0.000215	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.17e-05	0.000214	CcSEcCtD
Alitretinoin—Skin disorder—Epirubicin—stomach cancer	3.16e-05	0.000214	CcSEcCtD
Alitretinoin—Hyperhidrosis—Epirubicin—stomach cancer	3.14e-05	0.000213	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—stomach cancer	3.14e-05	0.000213	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—stomach cancer	3.14e-05	0.000212	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—stomach cancer	3.14e-05	0.000212	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—stomach cancer	3.14e-05	0.000212	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—stomach cancer	3.13e-05	0.000212	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—stomach cancer	3.12e-05	0.000211	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	3.12e-05	0.000211	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—stomach cancer	3.1e-05	0.00021	CcSEcCtD
Alitretinoin—Anorexia—Epirubicin—stomach cancer	3.1e-05	0.00021	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—stomach cancer	3.1e-05	0.00021	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—stomach cancer	3.09e-05	0.000209	CcSEcCtD
Alitretinoin—Dizziness—Capecitabine—stomach cancer	3.09e-05	0.000209	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—stomach cancer	3.07e-05	0.000208	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—stomach cancer	3.07e-05	0.000208	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—stomach cancer	3.06e-05	0.000207	CcSEcCtD
Alitretinoin—Rash—Docetaxel—stomach cancer	3.04e-05	0.000206	CcSEcCtD
Alitretinoin—Hypotension—Epirubicin—stomach cancer	3.04e-05	0.000206	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—stomach cancer	3.04e-05	0.000206	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—stomach cancer	3.04e-05	0.000205	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—stomach cancer	3.02e-05	0.000204	CcSEcCtD
Alitretinoin—Headache—Docetaxel—stomach cancer	3.02e-05	0.000204	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—stomach cancer	3.01e-05	0.000204	CcSEcCtD
Alitretinoin—Oedema—Doxorubicin—stomach cancer	3.01e-05	0.000204	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—stomach cancer	3e-05	0.000203	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—stomach cancer	3e-05	0.000203	CcSEcCtD
Alitretinoin—Infection—Doxorubicin—stomach cancer	2.99e-05	0.000202	CcSEcCtD
Alitretinoin—Pain—Methotrexate—stomach cancer	2.97e-05	0.000201	CcSEcCtD
Alitretinoin—Vomiting—Capecitabine—stomach cancer	2.97e-05	0.000201	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Epirubicin—stomach cancer	2.96e-05	0.000201	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—stomach cancer	2.96e-05	0.0002	CcSEcCtD
Alitretinoin—Nervous system disorder—Doxorubicin—stomach cancer	2.95e-05	0.0002	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—stomach cancer	2.95e-05	0.000199	CcSEcCtD
Alitretinoin—Rash—Capecitabine—stomach cancer	2.94e-05	0.000199	CcSEcCtD
Alitretinoin—Insomnia—Epirubicin—stomach cancer	2.94e-05	0.000199	CcSEcCtD
Alitretinoin—Dermatitis—Capecitabine—stomach cancer	2.94e-05	0.000199	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—stomach cancer	2.94e-05	0.000199	CcSEcCtD
Alitretinoin—Headache—Capecitabine—stomach cancer	2.93e-05	0.000198	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—stomach cancer	2.92e-05	0.000198	CcSEcCtD
Alitretinoin—Paraesthesia—Epirubicin—stomach cancer	2.92e-05	0.000198	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—stomach cancer	2.91e-05	0.000197	CcSEcCtD
Alitretinoin—Dyspnoea—Epirubicin—stomach cancer	2.9e-05	0.000196	CcSEcCtD
Alitretinoin—Somnolence—Epirubicin—stomach cancer	2.89e-05	0.000196	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—stomach cancer	2.87e-05	0.000194	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—stomach cancer	2.86e-05	0.000194	CcSEcCtD
Alitretinoin—Feeling abnormal—Methotrexate—stomach cancer	2.86e-05	0.000194	CcSEcCtD
Alitretinoin—Dyspepsia—Epirubicin—stomach cancer	2.86e-05	0.000194	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—stomach cancer	2.84e-05	0.000192	CcSEcCtD
Alitretinoin—Decreased appetite—Epirubicin—stomach cancer	2.83e-05	0.000191	CcSEcCtD
Alitretinoin—Hypotension—Doxorubicin—stomach cancer	2.81e-05	0.00019	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Epirubicin—stomach cancer	2.81e-05	0.00019	CcSEcCtD
Alitretinoin—Fatigue—Epirubicin—stomach cancer	2.8e-05	0.00019	CcSEcCtD
Alitretinoin—Constipation—Epirubicin—stomach cancer	2.78e-05	0.000188	CcSEcCtD
Alitretinoin—Pain—Epirubicin—stomach cancer	2.78e-05	0.000188	CcSEcCtD
Alitretinoin—Nausea—Capecitabine—stomach cancer	2.77e-05	0.000188	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—stomach cancer	2.76e-05	0.000187	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—stomach cancer	2.75e-05	0.000186	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—stomach cancer	2.75e-05	0.000186	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	2.74e-05	0.000186	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—stomach cancer	2.72e-05	0.000184	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—stomach cancer	2.7e-05	0.000183	CcSEcCtD
Alitretinoin—Dyspnoea—Doxorubicin—stomach cancer	2.68e-05	0.000182	CcSEcCtD
Alitretinoin—Feeling abnormal—Epirubicin—stomach cancer	2.68e-05	0.000181	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—stomach cancer	2.68e-05	0.000181	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Epirubicin—stomach cancer	2.66e-05	0.00018	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—stomach cancer	2.65e-05	0.000179	CcSEcCtD
Alitretinoin—Decreased appetite—Doxorubicin—stomach cancer	2.62e-05	0.000177	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.6e-05	0.000176	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—stomach cancer	2.6e-05	0.000176	CcSEcCtD
Alitretinoin—Urticaria—Epirubicin—stomach cancer	2.58e-05	0.000175	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—stomach cancer	2.57e-05	0.000174	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—stomach cancer	2.57e-05	0.000174	CcSEcCtD
Alitretinoin—Body temperature increased—Epirubicin—stomach cancer	2.57e-05	0.000174	CcSEcCtD
Alitretinoin—Abdominal pain—Epirubicin—stomach cancer	2.57e-05	0.000174	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—stomach cancer	2.56e-05	0.000173	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—stomach cancer	2.49e-05	0.000169	CcSEcCtD
Alitretinoin—Feeling abnormal—Doxorubicin—stomach cancer	2.48e-05	0.000168	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Doxorubicin—stomach cancer	2.46e-05	0.000167	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—stomach cancer	2.46e-05	0.000166	CcSEcCtD
Alitretinoin—Hypersensitivity—Epirubicin—stomach cancer	2.4e-05	0.000162	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—stomach cancer	2.39e-05	0.000162	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—stomach cancer	2.38e-05	0.000161	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—stomach cancer	2.38e-05	0.000161	CcSEcCtD
Alitretinoin—Diarrhoea—Methotrexate—stomach cancer	2.38e-05	0.000161	CcSEcCtD
Alitretinoin—Asthenia—Epirubicin—stomach cancer	2.33e-05	0.000158	CcSEcCtD
Alitretinoin—Pruritus—Epirubicin—stomach cancer	2.3e-05	0.000156	CcSEcCtD
Alitretinoin—Dizziness—Methotrexate—stomach cancer	2.3e-05	0.000156	CcSEcCtD
Alitretinoin—Diarrhoea—Epirubicin—stomach cancer	2.23e-05	0.000151	CcSEcCtD
Alitretinoin—Hypersensitivity—Doxorubicin—stomach cancer	2.22e-05	0.00015	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—stomach cancer	2.21e-05	0.00015	CcSEcCtD
Alitretinoin—Rash—Methotrexate—stomach cancer	2.19e-05	0.000148	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—stomach cancer	2.19e-05	0.000148	CcSEcCtD
Alitretinoin—Headache—Methotrexate—stomach cancer	2.18e-05	0.000147	CcSEcCtD
Alitretinoin—Asthenia—Doxorubicin—stomach cancer	2.16e-05	0.000146	CcSEcCtD
Alitretinoin—Dizziness—Epirubicin—stomach cancer	2.15e-05	0.000146	CcSEcCtD
Alitretinoin—Pruritus—Doxorubicin—stomach cancer	2.13e-05	0.000144	CcSEcCtD
Alitretinoin—Vomiting—Epirubicin—stomach cancer	2.07e-05	0.00014	CcSEcCtD
Alitretinoin—Nausea—Methotrexate—stomach cancer	2.06e-05	0.00014	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—stomach cancer	2.06e-05	0.000139	CcSEcCtD
Alitretinoin—Rash—Epirubicin—stomach cancer	2.05e-05	0.000139	CcSEcCtD
Alitretinoin—Dermatitis—Epirubicin—stomach cancer	2.05e-05	0.000139	CcSEcCtD
Alitretinoin—Headache—Epirubicin—stomach cancer	2.04e-05	0.000138	CcSEcCtD
Alitretinoin—Dizziness—Doxorubicin—stomach cancer	1.99e-05	0.000135	CcSEcCtD
Alitretinoin—Nausea—Epirubicin—stomach cancer	1.93e-05	0.000131	CcSEcCtD
Alitretinoin—Vomiting—Doxorubicin—stomach cancer	1.91e-05	0.00013	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—stomach cancer	1.9e-05	0.000128	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—stomach cancer	1.9e-05	0.000128	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—stomach cancer	1.89e-05	0.000128	CcSEcCtD
Alitretinoin—Nausea—Doxorubicin—stomach cancer	1.79e-05	0.000121	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.27e-05	9.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	1.26e-05	9.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACAD8—stomach cancer	1.26e-05	9.13e-05	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—stomach cancer	1.26e-05	9.12e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	1.25e-05	9.08e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.24e-05	8.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.24e-05	8.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	1.24e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	1.24e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	1.24e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—stomach cancer	1.23e-05	8.89e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—stomach cancer	1.23e-05	8.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	1.22e-05	8.84e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SREBF2—stomach cancer	1.21e-05	8.75e-05	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—stomach cancer	1.21e-05	8.74e-05	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—stomach cancer	1.21e-05	8.74e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—RORA—stomach cancer	1.2e-05	8.65e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—stomach cancer	1.19e-05	8.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.18e-05	8.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	1.18e-05	8.51e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	1.18e-05	8.51e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—stomach cancer	1.18e-05	8.5e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—stomach cancer	1.18e-05	8.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	1.17e-05	8.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.17e-05	8.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—stomach cancer	1.17e-05	8.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	1.17e-05	8.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	1.16e-05	8.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPB1—stomach cancer	1.15e-05	8.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MET—stomach cancer	1.14e-05	8.28e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CDK4—stomach cancer	1.14e-05	8.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GMPR2—stomach cancer	1.12e-05	8.14e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6ST—stomach cancer	1.12e-05	8.11e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RPS19—stomach cancer	1.12e-05	8.11e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALDOB—stomach cancer	1.12e-05	8.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—stomach cancer	1.12e-05	8.07e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—stomach cancer	1.1e-05	7.99e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—stomach cancer	1.09e-05	7.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—stomach cancer	1.08e-05	7.79e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.08e-05	7.79e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—stomach cancer	1.07e-05	7.78e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—stomach cancer	1.07e-05	7.78e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—DNMT1—stomach cancer	1.07e-05	7.75e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SERPINE1—stomach cancer	1.07e-05	7.74e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—stomach cancer	1.06e-05	7.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	1.06e-05	7.68e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.06e-05	7.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPA8—stomach cancer	1.06e-05	7.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.05e-05	7.62e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALOX5—stomach cancer	1.04e-05	7.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.04e-05	7.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—stomach cancer	1.04e-05	7.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH3B—stomach cancer	1.03e-05	7.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SUCLG1—stomach cancer	1.03e-05	7.44e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DPYD—stomach cancer	1.02e-05	7.41e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—stomach cancer	1.02e-05	7.38e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—stomach cancer	1.02e-05	7.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACAD8—stomach cancer	1.01e-05	7.29e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—APOA1—stomach cancer	1e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6R—stomach cancer	1e-05	7.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—stomach cancer	9.95e-06	7.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	9.92e-06	7.18e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RPS6—stomach cancer	9.91e-06	7.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	9.85e-06	7.12e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	9.78e-06	7.08e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—stomach cancer	9.78e-06	7.07e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SERPINE1—stomach cancer	9.59e-06	6.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—stomach cancer	9.57e-06	6.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NDUFV1—stomach cancer	9.56e-06	6.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NDUFS1—stomach cancer	9.56e-06	6.92e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—stomach cancer	9.55e-06	6.91e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.29e-06	6.72e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	9.26e-06	6.7e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	9.21e-06	6.66e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—stomach cancer	9.2e-06	6.65e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—stomach cancer	9.2e-06	6.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—stomach cancer	9.06e-06	6.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RHOA—stomach cancer	9.04e-06	6.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GMPR2—stomach cancer	8.98e-06	6.49e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2A6—stomach cancer	8.96e-06	6.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKR1C3—stomach cancer	8.71e-06	6.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	8.67e-06	6.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	8.58e-06	6.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	8.56e-06	6.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PGLS—stomach cancer	8.52e-06	6.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BLVRB—stomach cancer	8.52e-06	6.17e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ENO1—stomach cancer	8.49e-06	6.14e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—stomach cancer	8.37e-06	6.05e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.35e-06	6.04e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPP2R1A—stomach cancer	8.23e-06	5.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SUCLG1—stomach cancer	8.21e-06	5.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH3B—stomach cancer	8.21e-06	5.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPAP2A—stomach cancer	8.13e-06	5.88e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—stomach cancer	7.94e-06	5.74e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SMAD4—stomach cancer	7.65e-06	5.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NDUFV1—stomach cancer	7.63e-06	5.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NDUFS1—stomach cancer	7.63e-06	5.52e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD44—stomach cancer	7.53e-06	5.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	7.46e-06	5.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.31e-06	5.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA1—stomach cancer	7.25e-06	5.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FBP1—stomach cancer	7.25e-06	5.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CKB—stomach cancer	7.25e-06	5.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NDUFA2—stomach cancer	7.25e-06	5.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—stomach cancer	7.18e-06	5.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	7.15e-06	5.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	6.99e-06	5.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ERCC2—stomach cancer	6.98e-06	5.05e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—stomach cancer	6.96e-06	5.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLIN2—stomach cancer	6.81e-06	4.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BLVRB—stomach cancer	6.8e-06	4.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PGLS—stomach cancer	6.8e-06	4.92e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—stomach cancer	6.77e-06	4.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA2—stomach cancer	6.63e-06	4.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.62e-06	4.79e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—stomach cancer	6.61e-06	4.78e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—stomach cancer	6.61e-06	4.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPAP2A—stomach cancer	6.49e-06	4.7e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NT5E—stomach cancer	6.46e-06	4.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PGAM1—stomach cancer	6.46e-06	4.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—stomach cancer	6.44e-06	4.66e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPP2R1A—stomach cancer	6.4e-06	4.63e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—stomach cancer	6.38e-06	4.62e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—stomach cancer	6.36e-06	4.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.32e-06	4.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.3e-06	4.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—stomach cancer	6.3e-06	4.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—stomach cancer	6.28e-06	4.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.24e-06	4.52e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—stomach cancer	6.24e-06	4.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—stomach cancer	6.19e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—stomach cancer	6.19e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH7A1—stomach cancer	6.16e-06	4.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLCE1—stomach cancer	6.16e-06	4.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	6.11e-06	4.42e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—stomach cancer	6.1e-06	4.41e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—stomach cancer	6.07e-06	4.39e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—stomach cancer	5.98e-06	4.33e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—stomach cancer	5.98e-06	4.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.97e-06	4.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UMPS—stomach cancer	5.91e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—stomach cancer	5.84e-06	4.22e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—stomach cancer	5.82e-06	4.21e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—stomach cancer	5.82e-06	4.21e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK1—stomach cancer	5.8e-06	4.2e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—stomach cancer	5.8e-06	4.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA1—stomach cancer	5.79e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CKB—stomach cancer	5.79e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FBP1—stomach cancer	5.79e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NDUFA2—stomach cancer	5.79e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—stomach cancer	5.77e-06	4.18e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—stomach cancer	5.52e-06	4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.51e-06	3.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ECHS1—stomach cancer	5.49e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PDHA1—stomach cancer	5.49e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—stomach cancer	5.48e-06	3.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLIN2—stomach cancer	5.44e-06	3.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ERCC2—stomach cancer	5.43e-06	3.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—stomach cancer	5.32e-06	3.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA2—stomach cancer	5.29e-06	3.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.29e-06	3.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	5.21e-06	3.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FADS1—stomach cancer	5.16e-06	3.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMP—stomach cancer	5.16e-06	3.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NT5E—stomach cancer	5.16e-06	3.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PGAM1—stomach cancer	5.16e-06	3.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—stomach cancer	5.1e-06	3.69e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	5.07e-06	3.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.96e-06	3.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.96e-06	3.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH7A1—stomach cancer	4.92e-06	3.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLCE1—stomach cancer	4.92e-06	3.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SREBF2—stomach cancer	4.84e-06	3.5e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—stomach cancer	4.79e-06	3.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RORA—stomach cancer	4.78e-06	3.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.72e-06	3.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UMPS—stomach cancer	4.72e-06	3.41e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAV1—stomach cancer	4.7e-06	3.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA1—stomach cancer	4.69e-06	3.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.68e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—stomach cancer	4.66e-06	3.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.5e-06	3.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDOB—stomach cancer	4.48e-06	3.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—stomach cancer	4.46e-06	3.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PDHA1—stomach cancer	4.38e-06	3.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ECHS1—stomach cancer	4.38e-06	3.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.3e-06	3.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALOX5—stomach cancer	4.16e-06	3.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	4.16e-06	3.01e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—stomach cancer	4.14e-06	2.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMP—stomach cancer	4.12e-06	2.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FADS1—stomach cancer	4.12e-06	2.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DPYD—stomach cancer	4.1e-06	2.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	4.01e-06	2.9e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SREBF2—stomach cancer	3.86e-06	2.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RORA—stomach cancer	3.81e-06	2.76e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—stomach cancer	3.72e-06	2.69e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—stomach cancer	3.62e-06	2.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2A6—stomach cancer	3.58e-06	2.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDOB—stomach cancer	3.57e-06	2.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—stomach cancer	3.56e-06	2.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1C3—stomach cancer	3.48e-06	2.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO1—stomach cancer	3.39e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.37e-06	2.44e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.36e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALOX5—stomach cancer	3.32e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DPYD—stomach cancer	3.27e-06	2.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—stomach cancer	3.25e-06	2.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	3.17e-06	2.3e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—stomach cancer	3.12e-06	2.26e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—stomach cancer	3.03e-06	2.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD44—stomach cancer	3.01e-06	2.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.96e-06	2.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—stomach cancer	2.89e-06	2.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.86e-06	2.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.78e-06	2.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO1—stomach cancer	2.71e-06	1.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.66e-06	1.93e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—stomach cancer	2.51e-06	1.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—stomach cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD44—stomach cancer	2.4e-06	1.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—stomach cancer	2.33e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.33e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—stomach cancer	2.31e-06	1.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ERCC2—stomach cancer	2.17e-06	1.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.04e-06	1.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—stomach cancer	2.04e-06	1.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—stomach cancer	2e-06	1.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—stomach cancer	2e-06	1.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—stomach cancer	1.98e-06	1.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAV1—stomach cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA1—stomach cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—stomach cancer	1.86e-06	1.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—stomach cancer	1.84e-06	1.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ERCC2—stomach cancer	1.73e-06	1.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—stomach cancer	1.65e-06	1.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—stomach cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAV1—stomach cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA1—stomach cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—stomach cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—stomach cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—stomach cancer	1.32e-06	9.55e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—stomach cancer	1.3e-06	9.41e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—stomach cancer	1.19e-06	8.58e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—stomach cancer	1.13e-06	8.21e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—stomach cancer	1.04e-06	7.51e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—stomach cancer	8e-07	5.79e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—stomach cancer	6.39e-07	4.62e-06	CbGpPWpGaD
